Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |